Minireviews
Copyright ©The Author(s) 2015.
World J Gastrointest Endosc. Mar 16, 2015; 7(3): 258-264
Published online Mar 16, 2015. doi: 10.4253/wjge.v7.i3.258
Table 1 Endoscopic ultrasound in evaluating pancreatic mass lesions in patients with chronic pancreatitis
Ref.Study subjectsProcedureOutcome1
Fritscher-Ravens et al[19]74 patients with focal pancreatic lesions and chronic pancreatitisEUS FNASn-54%
Vardarajulu et al[17]75 patients with CP and focal pancreatic mass lesionEUS FNASn-73.9%
Sp-100%
Iordache et al[18]CP-55 CP and PC-17EUS FNASn-50%
Sp-73.7%
Hocke et al[13]86 patients with CP and pancreatic lesionEUSSn-73.2%
Sp-83.3%
CE-EUSSn-91.1%
Sp-93.3%
Table 2 Data from other studies on role of endoscopic ultrasound in evaluating pancreatic mass lesions
Ref.Study subjectsProcedureOutcome1
Ardengh et al[12]69 patients with pancreatic head massEUSSn-63.63%
Sp-75.86%
EUS FNASn-72.7%
Sp-100%
Das et al[16]Normal-22CP-12PC-22EUS, Digital image analysisSn-93%
Sp-92%
Zhu et al[15]CP-262EUS, Digital image analysisSn-96.25%
PC-126Sp-93.38%
Hirsche et al[32]70 patients with focal pancreatic lesionEUSSn-41%
ElastographySp-53%
Giovannini et al[33]121 patients with pancreatic mass lesionEUSSn-92.3%
Sp-68.9%
EUS ElastographySn-92.3%
Sp-80%
Iglesias-Garcia et al[35]78 patients with malignant pancreatic tumourEUS ElastographySn-100%
42 patients with inflammatory pancreatic massSp-85.5%
Iglesias-Garcia et al[30]86 patients with pancreatic mass (27 of them had inflammatory mass)Quantitative EUS ElastographySn-100%
Sp-92.9%
Seicean et al[38]30 patients with pancreatic lesion (12 had pseudotumour)CE harmonic-EUSSn-80%
Sp-91.7%
Saftoui et al[41]Focal pancreatic mass lesion (21 had pseudotumour)CE + elastography during EUSSn-75.85
Sp-95.2%
Saftoui et al[34]258 patients with focal pancreatic massQuantitative EUS ElastographySn-93.4%
Sp-66%
Hocke et al[14]Focal CP-39EUSSn-61.5%
Sp-73.7%
EUS elastographySn-33.4%
Sp-94.7%
PC-19CELMI-EUSSn-76.9%
Sp-84.2%
CEHMI-EUSSn-89.5%
Sp-84.2%
Gheona et al[40]PC-32Quantitative CE-EUSSn-93.7%
Pseudotumoural pancreatitis-19Sp-89.4%